CIK 0001607678
- Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461073877
- Phone
- +1 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 4 Open-market sale President & CEO sold 38,989 shares at $35.01 ($1,364,923)
- 4 Open-market sale Chief Financial Officer sold 6,185 shares at $35.00 ($216,481)
- 4 Open-market sale President & CEO sold 26,889 shares at $27.80 ($747,633)
- 4 Open-market sale Chief Financial Officer sold 4,266 shares at $27.76 ($118,428)
- 4 Open-market sale Chief Operating Officer sold 4,266 shares at $27.77 ($118,473)
- 4 Exercise or conversion Director acquired 20,786 shares (option exercise)
- 4/A Open-market buy Director bought 1,240 shares at $24.15 ($29,943)
- 4 Open-market buy Director bought 1,240 shares at $24.15 ($29,943)
- 4 Open-market sale President & CEO sold 194,490 shares at an average $42.75 ($8,313,601)
- 4 Open-market sale Chief Operating Officer sold 54,215 shares at an average $42.75 ($2,317,599)
- 4 Open-market sale Chief Financial Officer sold 50,309 shares at an average $42.75 ($2,150,595)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 2,000 shares at $68.67 ($137,333)
- 4 Planned sale Chief Financial Officer sold 131,687 shares at an average $76.61 ($10,089,164)
- 4 Planned sale Director sold 11,000 shares at $80.89 ($889,790)
- 4 Planned sale Director sold 16,000 shares at $79.50 ($1,272,000)
Page 2 of 11 · 216 filings